Company / Return on Equity (ROE)
Neogen Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-1.1%
FY2025
5-year range
-34.7% / 7.2%
FY2021-FY2025
Trend
+96.8%
vs FY2024
Sector context
#90 of 148
Health Care
What the data says
Neogen reports negative total equity of -1.1% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-1.1% in FY2025 with a 5-year CAGR of -9.8%.
Declined from -0.3% to -1.1% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -7.8pp
- 5-Year Change
- -9.8pp
- 10-Year Change
- -
Sector benchmark
#90 of 148 in Health CareTop 61% of 148This company -1.1% Sector average -3.2%
▼
+65.2% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 96.8% year-over-year.
- Currently 2.1pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2020.
- Lowest return on equity (roe) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1.1% | +96.8% |
| FY2024 | -34.7% | -11476.7% |
| FY2023 | -0.3% | -104.5% |
| FY2022 | 6.7% | -6.4% |
| FY2021 | 7.2% | -17.8% |
| FY2020 | 8.7% | +26.8% |
| FY2019 | 6.9% | +5.2% |
| FY2018 | 6.5% | -8.2% |
| FY2017 | 7.1% | +2.0% |
| FY2016 | 7.0% | -10.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026